News & Updates

Treatment with ranolazine in combination with class III antiarrhythmic drugs (AADs) is associated with improved maintenance of sinus rhythm (SR) 1 year after DC cardioversion (DCCV) relative to class III AAD alone, according to a study presented at EHRA 2024.

Use of angiotensin-converting enzyme inhibitors (ACEIs) often results in a poorer disease course at 5 and 10 years, whereas treatment with angiotensin receptor blockers (ARBs) is associated with fewer cases of corticosteroid use at 10 years, reports a study involving patients with Crohn’s disease (CD).

In individuals with advanced solid malignancies, subcutaneous (SC) amivantamab administered once a month is associated with fewer infusion-related reactions (IRRs) and offers more convenience than the IV formulation, the phase Ib PALOMA study suggest.

In children and adolescents, cardiorespiratory and muscular fitness appears to have a protective effect on the risk of incident mental disorders, according to a study.

The use of a venous closure system (VCS) post ablation for atrial fibrillation (AF) shortens ambulation time without recurrence of bleeding in the STYLE-AF study presented at EHRA 2024.

Treatment of monomorphic ventricular tachycardia (VT) with a novel ultra-low-temperature cryoablation catheter (vCLAS) eliminates VT in most patients with ischaemic or non-ischaemic cardiomyopathy in the first-in-human Cryocure-VT trial.